Pew Comments to Senate Finance Committee Regarding Availability and Use of Health Care Data

Navigate to:

Pew Comments to Senate Finance Committee Regarding Availability and Use of Health Care Data

On Tuesday, August 12, The Pew Charitable Trusts submitted comments to Senate Finance Committee chair Ron Wyden and senior Finance Committee member Chuck Grassley on the use of health data to better understand the effect of new medical products on patient outcomes.

Pew’s comments focus on needed reforms that will give patients and providers better information on medical device performance, including making registry findings publicly available, improving interoperability of electronic health records (EHRs), and incorporating unique device identification into electronic data sources, such as EHRs and health insurance claims.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.